Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Clover Health Investments ( (CLOV) ) is now available.
On October 31, 2025, Chelsea Clinton announced her departure from Clover Health’s Board of Directors after over eight years of service. Her tenure saw Clover’s transformation from a private company to a publicly traded entity serving over 100,000 seniors. Clinton’s contributions were pivotal in shaping the company’s mission-driven approach and technological advancements in healthcare. The Board plans to fill her vacancy promptly, maintaining its commitment to a diverse and experienced leadership team.
The most recent analyst rating on (CLOV) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Clover Health Investments stock, see the CLOV Stock Forecast page.
Spark’s Take on CLOV Stock
According to Spark, TipRanks’ AI Analyst, CLOV is a Neutral.
Clover Health’s stock score is influenced by its ongoing financial challenges, despite positive developments in operational metrics and an encouraging earnings call. The financial performance remains a significant concern due to negative margins and revenue decline. Technical indicators signal potential weakness, while valuation remains unattractive due to losses. The company’s achievements in profitability and membership growth offer potential for future improvement.
To see Spark’s full report on CLOV stock, click here.
More about Clover Health Investments
Clover Health is a physician enablement technology company focused on providing access to quality healthcare for Medicare beneficiaries, particularly seniors. The company leverages its software platform, Clover Assistant, to enhance clinical decision-making and improve health outcomes. Clover Health offers Medicare Advantage plans and extends its technology benefits to a broader audience through its subsidiary, Counterpart Health.
Average Trading Volume: 9,023,194
Technical Sentiment Signal: Buy
Current Market Cap: $1.78B
For detailed information about CLOV stock, go to TipRanks’ Stock Analysis page.